Annotation Detail for FES
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04360 | Axon guidance |
Pathway ID | Pathway Name |
---|
| Axon guidance |
Pathway ID | Pathway Name |
---|
200066 | Angiopoietin receptor Tie2-mediated signaling |
200018 | IL4-mediated signaling events |
200161 | Signaling events mediated by VEGFR1 and VEGFR2 |
Pathway ID | Pathway Name |
---|
P00007 | Axon guidance mediated by semaphorins |
Pathway ID | Pathway Name |
---|
500075 | SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
Desease ID | Desease Name |
---|
2009 | Sarcoma |
2053 | Colon cancer |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of FES mRNA | increases expression | 12634122
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FES mRNA | affects binding|decreases expression|increases activity | 19710929
|
D024505 |
Tocopherols |
Tocopherols results in increased expression of FES mRNA | increases expression | 17056531
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.64 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.22 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.63 | 19483382 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
4.28 | 2727394 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.15 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.59 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.96 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.25 | 19236843 20131406 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.78 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.64 | 19176532 16221962 19772884 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.63 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.90 | 16306350 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.94 | 20007298 16377806 15890375 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tocopherols |
4.34 | 17927505 |
MESH:D008654 |
Mesothelioma |
|
Tocopherols |
4.24 | 15878867 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
6.63 | 17671175 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.16 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.29 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.29 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.12 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.89 | 20558911 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tocopherols |
4.53 | 12504091 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.56 | 19058328 |